Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Journal of Cardiovascular Pharmacology|March 1, 1997
Cardiovascular and metabolic effects of adenosine A1-receptor agonists in streptozotocin-treated ratsB F Cox, K L Clark, M H Perrone, et al.European Journal of Pharmacology|April 10, 1990
Estimation of the in vivo effect of cyclooxygenase inhibitors on prostaglandin E2 levels in mouse brainR A Ferrari, S J Ward, C M Zobre, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1996
RPR 101821, a new potent cholesterol-lowering agent: inhibition of squalene synthase and 7-dehydrocholesterol reductaseD Amin, R Z Rutledge, S J Needle, et al.Thrombosis and Haemostasis|November 19, 1997
Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary arteryR J Leadley, C J Kasiewski, J S Bostwick, et al.Journal of Medicinal Chemistry|August 1, 1987
Synthesis and antidepressant properties of novel 2-substituted 4,5-dihydro-1H-imidazole derivativesM P Wentland, D M Bailey, E J Alexander, et al.The American Journal of Physiology|April 1, 1991
Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cellsG E Bilder, J A Krawiec, K McVety, et al.Pharmacology|January 1, 1993
RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agentD Amin, S K Gustafson, J M Weinacht, et al.Thrombosis Research|June 15, 1996
Anti-thrombotic activity of RG13965, a novel platelet fibrinogen receptor antagonistJ S Bostwick, C J Kasiewski, V Chu, et al.Journal of Cardiovascular Pharmacology|August 3, 2001
Role of short-term inhibition of factor Xa by FXV673 in arterial passivation: a study in a chronic model of thrombosis in conscious dogsS S Rebello, C J Kasiewski, W Wang, et al.Thrombosis Research|September 30, 2000
In vitro characterization of a novel factor Xa inhibitor, RPR 130737V Chu, K Brown, D Colussi, et al.Pageof 6